These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 21923692)

  • 21. Cutaneous Chromoblastomycosis Mimicking Tuberculosis Verrucosa Cutis: Look for Copper Pennies!
    Bandyopadhyay A; Majumdar K; Gangopadhyay M; Banerjee S
    Turk Patoloji Derg; 2015; 31(3):223-5. PubMed ID: 24272932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case of chromoblastomycosis due to Phialophora verrucosa responding to treatment with fluconazole.
    Guerriero C; De Simone C; Tulli A
    Eur J Dermatol; 1998; 8(3):167-8. PubMed ID: 9649717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case of chromoblastomycosis with an unusual clinical manifestation caused by Phialophora verrucosa on an unexposed area: treatment with a combination of amphotericin B and 5-flucytosine.
    Park SG; Oh SH; Suh SB; Lee KH; Chung KY
    Br J Dermatol; 2005 Mar; 152(3):560-4. PubMed ID: 15787829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Invasive chromoblastomycosis and sinusitis due to Phialophora verrucosa in a child from northern Africa.
    Hofmann H; Choi SM; Wilsmann-Theis D; Horré R; de Hoog GS; Bieber T
    Mycoses; 2005 Nov; 48(6):456-61. PubMed ID: 16262887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chromoblastomycosis.
    López Martínez R; Méndez Tovar LJ
    Clin Dermatol; 2007; 25(2):188-94. PubMed ID: 17350498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Fonsecaea pedrosoi-induced chromoblastomycosis: about a case].
    Baline K; Hali F
    Pan Afr Med J; 2018; 30():187. PubMed ID: 30455816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Septic arthritis and osteomyelitis due to the chromoblastomycosis agent Fonsecaea pedrosoi.
    De Guzman L; Perlman DC; Hubbard CE
    Am J Orthop (Belle Mead NJ); 2012 Jul; 41(7):328-31. PubMed ID: 22893884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromoblastomycosis in sub-tropical regions of India.
    Sharma A; Hazarika NK; Gupta D
    Mycopathologia; 2010 May; 169(5):381-6. PubMed ID: 20094803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case of chromoblastomycosis caused by Fonsecaea pedrosoi in a patient with rheumatoid arthritis.
    Ohashi T; Ohtsuka M; Kikuchi N; Nishiyama K; Suzutani T; Yamamoto T
    Int J Rheum Dis; 2015 Jun; 18(5):580-1. PubMed ID: 25293579
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of chromoblastomycosis with terbinafine: a report of four cases.
    Xibao Z; Changxing L; Quan L; Yuqing H
    J Dermatolog Treat; 2005 Apr; 16(2):121-4. PubMed ID: 16019628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Experimental Model of Chromoblastomycosis Caused by Fonsecaea sp. Species.
    Bocca AL; Siqueira IM
    Methods Mol Biol; 2023; 2667():129-138. PubMed ID: 37145281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chromoblastomycosis with underlying osteolytic lesion.
    Sharma NL; Sharma VC; Mahajan V; Shanker V; Sarin S
    Mycoses; 2007 Nov; 50(6):517-9. PubMed ID: 17944717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chromomycosis: report of a case with unusual topography].
    Muñoz Estrada VF; Valenzuela Paz GA; Rochín Tolosa M
    Rev Iberoam Micol; 2011; 28(1):50-2. PubMed ID: 21167297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fonsecaea pedrosoi as a rare cause of acute conjunctival ulceration.
    Adibelli FM; Karabicak N; Akal A; Goncu T; Yilmaz OF; Bayraktar M
    Arq Bras Oftalmol; 2016; 79(4):261-3. PubMed ID: 27626154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Case report. A case of chromoblastomycosis effectively treated with terbinafine. Characteristics of chromoblastomycosis in the Kitasato region, Japan.
    Tanuma H; Hiramatsu M; Mukai H; Abe M; Kume H; Nishiyama S; Katsuoka K
    Mycoses; 2000; 43(1-2):79-83. PubMed ID: 10838854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chromoblastomycosis: clinical experience and review of literature.
    Queiróz AJR; Pereira Domingos F; Antônio JR
    Int J Dermatol; 2018 Nov; 57(11):1351-1355. PubMed ID: 30113072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Photodynamic therapy combined with antifungal drugs against chromoblastomycosis and the effect of ALA-PDT on Fonsecaea in vitro.
    Hu Y; Qi X; Sun H; Lu Y; Hu Y; Chen X; Liu K; Yang Y; Mao Z; Wu Z; Zhou X
    PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007849. PubMed ID: 31671098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutaneous localized annular chromoblastomycosis.
    Salgado CG; da Silva MB; Yamano SS; Salgado UI; Diniz JA; da Silva JP
    J Cutan Pathol; 2009 Feb; 36(2):257-61. PubMed ID: 18727664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biology and pathogenesis of Fonsecaea pedrosoi, the major etiologic agent of chromoblastomycosis.
    Santos AL; Palmeira VF; Rozental S; Kneipp LF; Nimrichter L; Alviano DS; Rodrigues ML; Alviano CS
    FEMS Microbiol Rev; 2007 Sep; 31(5):570-91. PubMed ID: 17645522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chromoblastomycosis caused by Fonsecaea: clinicopathology, susceptibility and molecular identification of seven consecutive cases in Southern China.
    Yang YP; Li W; Huang WM; Zhou Y; Fan YM
    Clin Microbiol Infect; 2013 Nov; 19(11):1023-8. PubMed ID: 23153454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.